Clinical Trial Update: Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating temozolomide with ascorbic acid in recurrent high-grade glioma was terminated; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Oligodendroglioma
• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Ascorbic acid (Vitamin C)
• Temozolomide (Temozolomide)

Snippet

Sponsor: University of Nebraska | Conditions: Anaplastic Astrocytoma, Anaplastic Oligodendroglioma | Phase 1 | Status: TERMINATED | Results posted: 2018-02-23